Alan Enriquez, MD
Assistant Professor of Medicine (Cardiovascular Medicine); Director, Clinical Cardiac Electrophysiology Fellowship, Cardiovascular Medicine; Director, Cardiac Electrophysiology - VA Connecticut Healthcare System, Electrophysiology & Cardiac Arrhythmia Program
Research & Publications
Biography
News
Coauthors
Selected Publications
- Mortality and readmission in non-ischemic compared with ischemic cardiomyopathies after implantable cardioverter-defibrillator implantationFreeman J, Bjerre J, Parzynski C, Minges K, Ahmad T, Desai N, Enriquez A, Spatz E, Friedman D, Curtis J, Hlatky M, Higgins A. Mortality and readmission in non-ischemic compared with ischemic cardiomyopathies after implantable cardioverter-defibrillator implantation. European Heart Journal 2020, 41 DOI: 10.1093/ehjci/ehaa946.0788.
- Arrhythmias During Pregnancy and PostpartumEnriquez A, Tedrow U. Arrhythmias During Pregnancy and Postpartum. 2020, 645-669. DOI: 10.1007/978-3-030-41967-7_28.
- BUNDLE BRANCH REENTRANT VENTRICULAR TACHYCARDIA AFTER TRANSCATHETER AORTIC VALVE REPLACEMENTWorkman V, Freeman J, Forrest J, Upadhyaya K, Carney K, Enriquez A. BUNDLE BRANCH REENTRANT VENTRICULAR TACHYCARDIA AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT. Journal Of The American College Of Cardiology 2019, 73: 2934. DOI: 10.1016/s0735-1097(19)33540-5.
- Abstract 20924: Threshold Based Infrared Imaging for Prevention of Esophageal Thermal Injury During Atrial Fibrillation AblationHummel J, Kadado A, Baker M, Sadaf M, Gehi A, Bhatt P, Enriquez A, Freeman J, Marieb M, Mounsey P, Akar J. Abstract 20924: Threshold Based Infrared Imaging for Prevention of Esophageal Thermal Injury During Atrial Fibrillation Ablation. Circulation 2017, 136 DOI: 10.1161/circ.136.suppl_1.20924.
- Impact of general anesthesia on initiation and stability of VT during catheter ablationNof E, Reichlin T, Enriquez AD, Ng J, Nagashima K, Tokuda M, Barbhaiya C, John RM, Michaud GF, Tedrow U, Gross W, Stevenson WG. Impact of general anesthesia on initiation and stability of VT during catheter ablation. Heart Rhythm 2015, 12: 2213-2220. PMID: 26072026, DOI: 10.1016/j.hrthm.2015.06.018.
- Better outcome of ablation for sustained outflow-tract ventricular tachycardia when tachycardia is inducibleChoi EK, Kumar S, Nagashima K, Lin KY, Barbhaiya CR, Chinitz JS, Enriquez AD, Helmbold AF, Baldinger SH, Tedrow UB, Koplan BA, Michaud GF, John RM, Epstein LM, Stevenson WG. Better outcome of ablation for sustained outflow-tract ventricular tachycardia when tachycardia is inducible. EP Europace 2015, 17: 1571-1579. PMID: 25840288, DOI: 10.1093/europace/euv064.
- “Needle-in-needle” epicardial access: Preliminary observations with a modified technique for facilitating epicardial interventional proceduresKumar S, Bazaz R, Barbhaiya CR, Enriquez AD, Helmbold AF, Chinitz JS, Baldinger SH, Mahida S, McConville JW, Tedrow UB, John RM, Michaud GF, Stevenson WG. “Needle-in-needle” epicardial access: Preliminary observations with a modified technique for facilitating epicardial interventional procedures. Heart Rhythm 2015, 12: 1691-1697. PMID: 25828599, DOI: 10.1016/j.hrthm.2015.03.045.
- Incidence, predictors, and evolution of conduction disorders and atrial arrhythmias after contemporary mitral valve repairViles-Gonzalez JF, Enriquez AD, Castillo JG, Coffey JO, Pastori L, Reddy VY, Adams DH, Fuster V. Incidence, predictors, and evolution of conduction disorders and atrial arrhythmias after contemporary mitral valve repair. Cardiology Journal 2014, 21: 569-575. PMID: 24526511, DOI: 10.5603/cj.a2014.0016.
- Clinical Impact of Atrial Fibrillation in Patients With the HeartMate II Left Ventricular Assist DeviceEnriquez AD, Calenda B, Gandhi PU, Nair AP, Anyanwu AC, Pinney SP. Clinical Impact of Atrial Fibrillation in Patients With the HeartMate II Left Ventricular Assist Device. Journal Of The American College Of Cardiology 2014, 64: 1883-1890. PMID: 25444141, DOI: 10.1016/j.jacc.2014.07.989.
- Contemporary Management of Arrhythmias During PregnancyEnriquez AD, Economy KE, Tedrow UB. Contemporary Management of Arrhythmias During Pregnancy. Circulation Arrhythmia And Electrophysiology 2014, 7: 961-967. PMID: 25336366, DOI: 10.1161/circep.114.001517.
- Avoiding tachycardia alteration or termination during attempted entrainment mapping of atrial tachycardia related to atrial fibrillation ablationBarbhaiya CR, Kumar S, Ng J, Nagashima K, Choi EK, Enriquez A, Chinitz J, Epstein LM, Tedrow UB, John RM, Stevenson WG, Michaud GF. Avoiding tachycardia alteration or termination during attempted entrainment mapping of atrial tachycardia related to atrial fibrillation ablation. Heart Rhythm 2014, 12: 32-35. PMID: 25194901, DOI: 10.1016/j.hrthm.2014.09.002.
- Correlates and Prognosis of Early Recurrence After Catheter Ablation for Ventricular Tachycardia due to Structural Heart DiseaseNagashima K, Choi EK, Tedrow UB, Koplan BA, Michaud GF, John RM, Epstein LM, Tokuda M, Inada K, Kumar S, Lin KY, Barbhaiya CR, Chinitz JS, Enriquez AD, Helmbold AF, Stevenson WG. Correlates and Prognosis of Early Recurrence After Catheter Ablation for Ventricular Tachycardia due to Structural Heart Disease. Circulation Arrhythmia And Electrophysiology 2014, 7: 883-888. PMID: 25136076, DOI: 10.1161/circep.114.001461.
- Management of Hypertrophic CardiomyopathyEnriquez AD, Goldman ME. Management of Hypertrophic Cardiomyopathy. Annals Of Global Health 2014, 80: 35-45. PMID: 24751563, DOI: 10.1016/j.aogh.2013.12.004.
- THE CLINICAL IMPACT OF ATRIAL FIBRILLATION IN PATIENTS WITH THE HEARTMATE II LEFT VENTRICULAR ASSIST DEVICEEnriquez A, Calenda B, Gandhi P, Nair A, Anyanwu A, Pinney S. THE CLINICAL IMPACT OF ATRIAL FIBRILLATION IN PATIENTS WITH THE HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE. Journal Of The American College Of Cardiology 2014, 63: a888. DOI: 10.1016/s0735-1097(14)60888-3.
- (518) The Clinical Impact of Atrial Fibrillation in Patients with the HeartMate II Left Ventricular Assist DeviceEnriquez A, Brandon C, Gandhi P, Nair A, Anyanwu A, Pinney S. (518) The Clinical Impact of Atrial Fibrillation in Patients with the HeartMate II Left Ventricular Assist Device. The Journal Of Heart And Lung Transplantation 2014, 33: s193. DOI: 10.1016/j.healun.2014.01.525.
- The Role of Implantable Cardioverter-Defibrillators in Patients With Continuous Flow Left Ventricular Assist DevicesEnriquez AD, Calenda B, Miller MA, Anyanwu AC, Pinney SP. The Role of Implantable Cardioverter-Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices. Circulation Arrhythmia And Electrophysiology 2013, 6: 668-674. PMID: 23873139, DOI: 10.1161/circep.113.000457.
- Implantable Cardioverter-Defibrillators Do Not Reduce Mortality in Patients with the HeartMate II Left Ventricular Assist DeviceEnriquez A, Calenda B, Anyanwu A, Pinney S. Implantable Cardioverter-Defibrillators Do Not Reduce Mortality in Patients with the HeartMate II Left Ventricular Assist Device. The Journal Of Heart And Lung Transplantation 2013, 32: s25. DOI: 10.1016/j.healun.2013.01.046.
- IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS DO NOT REDUCE MORTALITY IN PATIENTS WITH THE HEARTMATE II LEFT VENTRICULAR ASSIST DEVICEEnriquez A, Calenda B, Anyanwu A, Pinney S. IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS DO NOT REDUCE MORTALITY IN PATIENTS WITH THE HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE. Journal Of The American College Of Cardiology 2013, 61: e775. DOI: 10.1016/s0735-1097(13)60775-5.
- Human oligodendrocytes express Cx31.3: function and interactions with Cx32 mutants.Sargiannidou I, Ahn M, Enriquez AD, Peinado A, Reynolds R, Abrams C, Scherer SS, Kleopa KA. Human oligodendrocytes express Cx31.3: function and interactions with Cx32 mutants. Neurobiology Of Disease 2008, 30: 221-33. PMID: 18353664, PMCID: PMC2704064, DOI: 10.1016/j.nbd.2008.01.009.
- Cx29 and Cx32, two connexins expressed by myelinating glia, do not interact and are functionally distinct.Ahn M, Lee J, Gustafsson A, Enriquez A, Lancaster E, Sul JY, Haydon PG, Paul DL, Huang Y, Abrams CK, Scherer SS. Cx29 and Cx32, two connexins expressed by myelinating glia, do not interact and are functionally distinct. Journal Of Neuroscience Research 2008, 86: 992-1006. PMID: 17972320, PMCID: PMC2663799, DOI: 10.1002/jnr.21561.
- Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosis.Enriquez AD, Campbell MS, Reddy KR. Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosis. Alimentary Pharmacology & Therapeutics 2007, 26: 383-91. PMID: 17635373, DOI: 10.1111/j.1365-2036.2007.03382.x.
- Loss-of-function GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like disease.Orthmann-Murphy JL, Enriquez AD, Abrams CK, Scherer SS. Loss-of-function GJA12/Connexin47 mutations cause Pelizaeus-Merzbacher-like disease. Molecular And Cellular Neurosciences 2007, 34: 629-41. PMID: 17344063, PMCID: PMC1937038, DOI: 10.1016/j.mcn.2007.01.010.
- Unique distributions of the gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes.Kleopa KA, Orthmann JL, Enriquez A, Paul DL, Scherer SS. Unique distributions of the gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes. Glia 2004, 47: 346-57. PMID: 15293232, DOI: 10.1002/glia.20043.